O. Kurnaz-Gomleksiz Et Al. , "The Role of PPAR-gamma C161T Polymorphism in Colorectal Cancer Susceptibility," IN VIVO , vol.36, no.4, pp.1911-1915, 2022
Kurnaz-Gomleksiz, O. Et Al. 2022. The Role of PPAR-gamma C161T Polymorphism in Colorectal Cancer Susceptibility. IN VIVO , vol.36, no.4 , 1911-1915.
Kurnaz-Gomleksiz, O., Torun, B. C., Isbir, T., Bulut, T., Sokucu, N., Yilmaz-Aydogan, H., ... Canbay, E.(2022). The Role of PPAR-gamma C161T Polymorphism in Colorectal Cancer Susceptibility. IN VIVO , vol.36, no.4, 1911-1915.
Kurnaz-Gomleksiz, Ozlem Et Al. "The Role of PPAR-gamma C161T Polymorphism in Colorectal Cancer Susceptibility," IN VIVO , vol.36, no.4, 1911-1915, 2022
Kurnaz-Gomleksiz, Ozlem Et Al. "The Role of PPAR-gamma C161T Polymorphism in Colorectal Cancer Susceptibility." IN VIVO , vol.36, no.4, pp.1911-1915, 2022
Kurnaz-Gomleksiz, O. Et Al. (2022) . "The Role of PPAR-gamma C161T Polymorphism in Colorectal Cancer Susceptibility." IN VIVO , vol.36, no.4, pp.1911-1915.
@article{article, author={Ozlem Kurnaz-Gomleksiz Et Al. }, title={The Role of PPAR-gamma C161T Polymorphism in Colorectal Cancer Susceptibility}, journal={IN VIVO}, year=2022, pages={1911-1915} }